DBD stock: buy or sell?

DBD stock price: $7.85 -1.13% At close on November 19th, 2019

Updated on:
November 19th, 2019

1

Diebold Nixdorf shares decreased -1.13% to $7.85 today.

Diebold Nixdorf, Incorporated provides connected commerce services, software, and technology for financial, commercial, and industrial customers.

Should I buy DBD stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Diebold Nixdorf stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Diebold Nixdorf stock a buy?

Banks and financial institutions publish stock ratings everyday. At Stocks2.com, we collected 2 ratings published for DBD stock in the last month.

Is DBD a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-17Sidotin/aBuy
2019-2-14JPMorgan Chase & Co.n/aSell

DBD stock analysis

Daily outlook

Shares of Diebold Nixdorf closed today at $7.85 and decreased a bad -1.13%.

Diebold Nixdorf decreased a bad -1.13% and closed at $7.85. Since price and SMA200d lines crossed down on October 8th, DBD fell $-1.94 per share (-19.82%).

DBD stock chart (daily)

Weekly outlook

Diebold Nixdorf slipped a horrible -3.56% this week. Late October DBD collapsed a frightening -28.88% in just one week. Early November DBD boosted an astounding 10.10% in just one week.

Since SMA20w and SMA40w crossed up early April, DBD price slid a -29.09%. Since price and SMA40w lines crossed up by mid February, DBD climbed $2.84 (56.69%).

DBD stock chart (weekly)

DBD stock price history

DBD stock went public on December 31st, 1981 with a price of $2.071. Since then, DBD stock grew a 279.20%, with a yearly average of 7.50%. If you had invested right after DBD's IPO a $1,000 in DBD stock in 1981, it would worth $2,792.00 today.

1: Adjusted price after possible price splits or reverse-splits.

DBD stock historical price chart

DBD stock reached 52-week highs on July at $14.66, and all-time highs 2005-04-07 with a price of 38.51.

DBD stock price target is $7.00

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. Currently, only 1 price forecast for Diebold Nixdorf stock was posted in the last month:
DBD stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-2-14JPMorgan Chase & Co.Set Price Targetn/a$7.00-
(in average)$0.00$7.000.0%

Financials and fundamental analysis

Earnings date and Earnings per Share

Since February, when Diebold Nixdorf posted its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will extend this report.
DBD earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a-0.35n/a
2017-Q32017-10-310.140.58314.3%
2017-Q42018-02-130.350.414.3%
2018-Q12018-05-020.01-0.12n/a
2018-Q22018-08-010.01-0.21n/a
2018-Q32018-10-31-0.09-0.61n/a
2018-Q42019-02-13n/a-0.08n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, Diebold Nixdorf annual turnover remained stable a bad -0.67% to $4,578.60 million USD from $4,609.30 marked in 2017. However, its income margin (compared to revenues) dropped to -12.42%, that is $-568.70 million.

DBD annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$2,860 M-$-181.61 M-6.3%-
2014$3,051 M6.68%$114 M3.8%-163.00%
2015$2,419 M-20.71%$74 M3.0%-35.59%
2016$3,316 M37.08%$-33.00 M-1.0%-144.78%
2017$4,609 M38.99%$-241.50 M-5.2%631.82%
2018$4,579 M-0.67%$-568.70 M-12.4%135.49%

Quarterly financial results

Diebold Nixdorf posted $1,289.80 M in sales for 2018-Q4, a 15.26% improvement compared to previous quarter. Reported quarter earnings marked $-145.50 M with a profit margin of -11.28%. Profit margin rose a 7.72% compared to previous quarter when profit margin was -19.00%. When comparing revenues to same quarter last year, Diebold Nixdorf sales marked a nice growth and grew a 3.19%. Looking back to recent quarterly results, Diebold Nixdorf posted 3 negative quarters in a row.
DBD quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$1,130 M-$-30.60 M-2.7%-
2017-Q3$1,123 M-0.65%$-35.40 M-3.2%15.69%
2017-Q4$1,250 M11.33%$-106.40 M-8.5%200.56%
2018-Q1$1,064 M-14.86%$-70.90 M-6.7%-33.36%
2018-Q2$1,106 M3.89%$-138.50 M-12.5%95.35%
2018-Q3$1,119 M1.21%$-212.60 M-19.0%53.50%
2018-Q4$1,290 M15.26%$-145.50 M-11.3%-31.56%
2019-Q1$1,028 M-20.29%$-132.70 M-12.9%-8.80%

Diebold Nixdorf ownership

When you are planning to buy a company, it's worth to review its ownership structure.

Diebold Nixdorf shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 2.39% of all shares.

Bearish positions for DBD stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Diebold Nixdorf:

DBDBCONCRPARPBI
Market cap$602.8 M$4.5 B$4.3 B$505.5 M$743.2 M
Total shares76.8 M50.0 M129.5 M16.4 M170.9 M
Float shares75.6 M49.3 M119.5 M8.5 M169.4 M
  - Institutional holdings (%)99.2%105.1%98.8%59.5%74.1%
  - Insider holdings (%)2.4%1.1%1.3%33.8%0.5%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

DBD summary

Tuesday, November 19th, 2019
Open$7.95
Close$7.85
Day range$7.71 - $8.01
Previous close$7.94
Session gain-1.13%
Average true range$0.47
50d mov avg$9.90
100d mov avg$10.76
200d mov avg$10.33
Daily pattern
Weekly pattern lt03c

Diebold Nixdorf performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We picked Brink's, NCR, PAR Technology, Pitney Bowes and USA Technologies as the bechmarking frame for Diebold Nixdorf stock.
Stock3m6m12m
DBDDiebold Nixdorf-32.21%-14.77%116.25%
BCOBrink's25.06%14.22%38.76%
NCR 10.00%7.33%32.52%
PARPAR Technology40.16%14.35%73.71%
PBIPitney Bowes21.85%-3.76%-42.91%
USATUSA Technologies-17.59%-7.99%29.90%

Diebold Nixdorf competitors

One check before trading any stock is to review a list of its competitors, in this case for Diebold Nixdorf. We picked 5 companies as Diebold Nixdorf competitors as they are in the same industry or have similar market objectives.